Release of Draft (Step 2) International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance: Q3C(R6): Impurities: Guideline for Residual Solvents
Notice to the reader:
The online consultation is now closed.
The above referenced draft guidance was released by the ICH Steering Committee for consultation and is being posted on the ICH website for information and comment in accordance with Step 2 of the ICH process.
How to Get Involved
This consultation is open for comment starting August 19, 2015 until November 17, 2015. Please select and read through the link below titled "consultation document". Once read, please submit your comments via email, fax or by mail to:
Alisa Vespa
Bureau of Metabolism, Oncology and Reproductive Sciences
Therapeutic Products Directorate
Health Products and Food Branch
Health Canada
1600 Scott St, Holland Cross
Ottawa, Ontario
K1A0K9
Email: alisa.vespa@hc-sc.gc.ca
Telephone: 613-261-2997
Fax: 613-941-3694
Interested parties are encouraged to provide comments and suggestions by November 17, 2015.
Reporting to Canadians
Health Canada will make the results of this consultation available on this Web site.
If you have any questions, contact Alisa Vespa.